The first FDA De Novo designated NGS assay for detecting HIV-1 drug resistance mutations (DRMs)
We are fully prepared for the global launch of LY03004 and other innovative formulations
From China, for the world
Luye Pharma and AstraZeneca signing a Memorandum of Understanding (MOU) for intent to form a new strategic par...
Liu Dianbo, Chairman of the Board of Directors of Luye Life Sciences Group, chaired the parallel session on “...
Luye Pharma will have exclusive rights to develop and commercialize Zepsyre® for Small Cell Lung Cancer and al...
TOP